All News


 

2023

January

Media Release / Jan 10, 2023

Sandoz Canada Launches PrSandoz® Sitagliptin and PrSandoz® Sitagliptin-Metformin

Read More
2022

December

Media Release / Dec 21, 2022

Sandoz Canada supports Ontario policy change to cover biosimilars which will generate significant cost savings and improve patient access to quality medicines

Read More

November

Media Release / Nov 14, 2022

Sandoz Canada launches PrSandoz® Apremilast

Read More

October

Media Release / Oct 25, 2022

Novartis Q3 2022 financial results

Read More

September

Media Release / Sep 21, 2022

Sandoz Canada continues to expand its portfolio of generic products

Read More

August

Media Release / Aug 25, 2022

Novartis announces intention to separate Sandoz business to create a standalone company by way of a 100% spin-off

Read More

July

Media Release / Jul 19, 2022

Novartis Q2 2022 Financial Results

Read More
Media Release / Jul 05, 2022

Sandoz Canada expands its generics portfolio with three new products

Read More

June

Media Release / Jun 30, 2022

Delpharm production activities resume and Sandoz confirms over 90% availability of its injectables

Read More
Media Release / Jun 17, 2022

Strength of Sandoz Canada supply chain minimizes potential impact of Delpharm strike

Read More